InsidersTradesSigma
康华生物: management transactions · France · AMF
SZSE:300841FR·AMFMcap 9.4Bn€
Browse the full directors' dealings record of 康华生物, a publicly traded company based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €9.4bn. The latest transaction was filed on 21 November 2023 — Sale. Among the most active insiders: 三明玖日广隶商贸合伙企业(有限合伙). All data is free.
12
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
12 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
53.94 €
Income statement
Revenue1.17 Bn€
Gross profit1.07 Bn€92% margin
Net income219.9 M€18.9% margin
Balance sheet & cash
Market cap9.39 Bn€
Total debt139.9 M€
Free Cash Flow308.9 M€
Last declaration on 21 November 2023
Declarations12 total
12 of 12 declarations